Early studies on Gly-His-Lys (GHK), first discovered in human plasma in the 1970s, demonstrated their ability to modulate gene expression, stimulate collagen synthesis, and accelerate wound healing, sparking broad interest in these bioactive molecules [23]
Studies that used 1 mg/day in oral and intravenous trials did not show meaningfully better outcomes than lower doses, and higher doses were associated with more reports of headache, diarrhea, and gastrointestinal effects
E.MajounieE.WaiteA.Simn-SnchezJ.RollinsonS.GibbsJ
GHK-Cu is not FDA-approved for anti-aging or cosmetic indications
I had moved from the morbidly obese category to obese according to the very outdated BMI chart I still cringe at
Patients often explore Ipamorelin for sleep support, recovery, and overall wellness goals